Severe jaundice leading to kernicterus or death in the newborn is the most devastating consequence of glucose-6-phosphate dehydrogenase (EC 1.1.1.49; G-6-PD) deficiency, We asked whether the TA repeat promoter polymorphism in the gene for uridinediphospboglucuronate glucuronasyltransferase 1 (EC 2.4.1.17; UDPGT1), associated with benign jaundice in adults (Gilbert syndrome), increases the incidence of neonatal hyperbilirubinemia in G-6-PD deficiency. DNA from term neonates was analyzed fur UDPGT1 polymorphism (normal homozygotes, heterozygotes, variant homozygotes), and for G-6-PD Mediterranean deficiency, The variant UDPGT1 promoter allele frequency was similar in G-6-PD-deficient and normal neonates, Thirty (22.9%) G-6-PD deficient neonates developed serum total bilirubin greater than or equal to 257 mu mol/liter, vs, 22 (9.2%) normals (P = 0.0005). Of those with ;he normal homozygous UDPGT1 genotype, the incidence of hyperbilirubinemia was similar in G-6-PD-deficients and controls (9.7% and 9.9%), In contrast, in the G-6-PD-deficient neonates, those with the heterozygous or homozygous variant UDPGT1 genotype had a higher incidence of hyperbilirubinemia than corresponding controls (heterozygotes: 31.4% vs, 6.7%, P < 0.0001; variant homozygotes: 50% vs, 14.7%, P = 0.02). Among G-6-PD-deficient infants the incidence of hyperbilirubinemia was greater in those with the heterozygous (31.6%, P = 0.006) or variant homozygous (50%, P = 0.003) UDPGT1 genotype than in normal homozygotes. In contrast, among those normal for G-fl-PD, the UDPGT1 polymorphism had no significant effect (heterozygotes: 6.7%; variant homozygotes: 14.7%), Thus, neither G-6-PD deficiency nor the variant UDPGT1 promoter, alone, increased the incidence of hyperbilirubinemia, bur both in combination did, This gene interaction may serve as a paradigm of the interaction of benign genetic polymorphisms in the causation of disease.
